Effectiveness of Sugammadex on Muscle Relaxant Reversal in Preterm Neonates
Status:
Recruiting
Trial end date:
2021-02-01
Target enrollment:
Participant gender:
Summary
The primary aim of the work is to compare the efficacy of Sugammadex and neostigmine in
reversing rocuronium-induced muscle relaxation to reach complete recovery of neuromuscular
block (TOF ratio≥ 0.9) in preterm neonates.
The secondary aim is to evaluate the safety of using Sugammadex in preterm neonates and to
detect any complications that may occur in this age group.